作者: CE Teunissen , Axel Petzold , Jeffrey L Bennett , Frode S Berven , Lou Brundin
DOI: 10.1212/WNL.0B013E3181C47CC2
关键词:
摘要: There is a long history of research into body fluid biomarkers in neurodegenerative and neuroinflammatory diseases. However, only few CSF are being used clinical practice. One the most critical factors biomarker inadequate powering studies because lack sufficient samples that can be obtained single-center studies. Therefore, collaboration between investigators needed to establish large biobanks well-defined samples. Standardized protocols for biobanking prerequisite ensure statistical power gained by increasing numbers not compromised preanalytical factors. Here, consensus report on recommendations collection presented, formed BioMS-eu network multiple sclerosis. We focus procedures, factors, high-quality paraclinical information. The applicable targeting any neurologic disease.